Trial · NCT01439711
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Mean Total MRI Functional Tumor Volume (FTV) Change From Baseline to Month 3 (V3) | up to 3 months from start of treatment | cubic centimeters | MEAN | |
| PRIMARY | Mean Total MRI Functional Tumor Volume (FTV) Change From Baseline to Month 6 (V6) | up to 6 months from start of treatment | cubic centimeters | MEAN | |
| SECONDARY | Mean Total MRI Tumor Diameter Change From Baseline to Month 3 | 3-months | millimeters | MEAN | |
| SECONDARY | Change in Maximum Diameter at 6-months Based on Mammographic Measurement (MD6) | 6-months | Patients who completed a mammogram at both time points (baseline and month 6) with measurements available were included in this analysis. | millimeters | MEAN |
| SECONDARY | Type of Primary Surgery (Mastectomy or Lumpectomy) | up to 6 months | Patients who underwent surgery were included in this analysis. | percentage of surgeries | NUMBER |
| SECONDARY | Number of Re-excisions Required to Obtain Clear Margins | 3-months and 6-months | |||
| SECONDARY | Extent of Residual DCIS Post Surgery | Up to 6 months post-surgery | |||
| SECONDARY | Presence of Invasive Cancer at Surgery | 3-months and 6-months | |||
| SECONDARY | Size of Margins (Smallest) at Surgery | 3-months and 6-months | |||
| SECONDARY | Incidence of Toxicity as Assessed by the National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0 | Up to 6 months post surgery | Patients who had completed the study and had an Adverse Event Form submitted were included in this analysis. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Mean Total MRI Tumor Diameter Change From Baseline to Month 6 | 6 months | millimeters | MEAN | |
| SECONDARY | Mean Total MRI Tumor Diameter Change From Baseline to Month 6 | 6 months | millimeters | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01439711/outcomes